Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly NYSE:LLY |
1.008,93 B | 23,47% | 6/6 | 38,18% | 3,56% | 10,57% | UP |
|
Merck NYSE:MRK |
297,02 B | 7,71% | 6/6 | -21,58% | -15,73% | 12,26% | UP |
|
Pfizer NYSE:PFE |
148,41 B | 7,82% | 3/6 | -4,89% | 24,13% | 7,53% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
115,58 B | 1,77% | 5/6 | 0,08% | 1,65% | 14,84% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
112,12 B | 13,44% | 5/6 | 6,55% | -2,37% | 25,64% | UP |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
63,97 B | 9,26% | 5/6 | 7,53% | 20,57% | 35,59% | DOWN |
|
Zoetis NYSE:ZTS |
33,34 B | 10,27% | 6/6 | 6,74% | 64,77% | 63,48% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
23,25 B | 15,46% | 5/6 | 2,37% | -37,45% | 25,07% | UP |
|
Viatris NasdaqGS:VTRS |
18,52 B | -3,61% | 5/6 | 3,43% | -59,91% | 13,21% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
11,36 B | 0,00% | 1/4 | 0,00% | 0,00% | 31,18% | UP |
|
Cytokinetics NasdaqGS:CYTK |
9,82 B | -1,86% | 1/6 | 9,11% | -52,14% | 43,86% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
8,04 B | 7,35% | 3/6 | 131,43% | -28,11% | 0,15% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
5,75 B | 63,06% | 3/5 | 42,79% | 92,38% | 23,27% | UP |
|
Balchem NasdaqGS:BCPC |
5,08 B | 8,75% | 6/6 | 8,46% | 9,85% | 28,15% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,73 B | 7,75% | 5/6 | 10,78% | -68,93% | 15,51% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,22 B | 30,35% | 5/6 | 12,29% | 10,11% | 41,56% | DOWN |
|
Soleno Therapeutics NasdaqGM:SLNO |
2,76 B | 0,00% | 3/4 | 0,00% | 0,00% | -0,02% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,59 B | 2,25% | 3/6 | 7,50% | -10,34% | 43,18% | DOWN |
|
Endo OTCPK:NDOI |
1,80 B | 3,65% | 0/5 | 61,08% | 23,81% | -100,00% | DOWN |
